Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Vitamin D Status and Reproductive Hormonal Profiles in Early Versus Physiological Menopause: A Comparative Observational Study.

Biomedicines·2026

Same author

Obstetric Outcomes Among Underage Mothers: Age-Stratified Analysis from a Romanian Hospital-Based Cohort.

Medicina (Kaunas, Lithuania)·2026

Same author

PI-RADS v2 and Adverse Prostate Cancer Outcomes: A Cross-cohort Replication Study Across Three Centers.

European urology oncology·2026

Same author

Raman spectroscopy as a diagnostic tool for glioma: protocol for a systematic review.

Diagnostic and prognostic research·2026

Same author

Comparable recurrence risk for MRI-detected Gleason Grade Group (GG) 2 and systematic biopsy-detected GG1 prostate cancer.

BJU international·2025

Same author

Transforming critical care: the digital revolution's impact on intensive care units.

Frontiers in digital health·2025

Same journal

Turbulent flow in a vortex separator with a directed pipe inlet.

Scientific reports·2026

Same journal

Systematic characteristic evaluation of clay-based cementitious material derived from calcium carbide residue and waste tile powder.

Scientific reports·2026

Same journal

Retraction Note: Improvement of a rapid diagnostic application of monoclonal antibodies against avian influenza H7 subtype virus using Europium nanoparticles.

Scientific reports·2026

Same journal

Applying large language models to spam detection in the Kazakh low-resource language setting.

Scientific reports·2026

Same journal

An open-source 3D printing system enabling in-situ freeze-thaw processing of hydrogels.

Scientific reports·2026

Same journal

An enhanced EfficientNet framework for automated waste classification using cosine annealing and label smoothing.

Scientific reports·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Oct 5, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Network controllability solutions for computational drug repurposing using genetic algorithms.

Victor-Bogdan Popescu¹, Krishna Kanhaiya¹, Dumitru Iulian Năstac²

¹Computer Science, Åbo Akademi University, 20500, Turku, Finland.

Scientific Reports

|January 27, 2022

Summary

This summary is machine-generated.

This study introduces a novel genetic algorithm to identify minimal drug targets for network control, enhancing drug repurposing for diseases like cancer by efficiently analyzing protein-protein interaction networks.

More Related Videos

Optimizing the Use of a Liquid Handling Robot to Conduct a High Throughput Forward Chemical Genetics Screen of Arabidopsis thaliana

Optimizing the Use of a Liquid Handling Robot to Conduct a High Throughput Forward Chemical Genetics Screen of Arabidopsis thaliana

Published on: April 30, 2018

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Related Experiment Videos

Last Updated: Oct 5, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Optimizing the Use of a Liquid Handling Robot to Conduct a High Throughput Forward Chemical Genetics Screen of Arabidopsis thaliana

Optimizing the Use of a Liquid Handling Robot to Conduct a High Throughput Forward Chemical Genetics Screen of Arabidopsis thaliana

Published on: April 30, 2018

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Area of Science:

Network science
Control theory
Computational biology

Background:

Network controllability is crucial for understanding and intervening in complex systems.
Applications in network medicine highlight the need for efficient control strategies.
Identifying minimal interventions is key for targeted therapeutic approaches.

Purpose of the Study:

To develop a novel genetic algorithm for network controllability.
To apply this algorithm to identify optimal drug targets for computational drug repurposing.
To enhance the identification of FDA-approved drug targets within disease-specific networks.

Main Methods:

Utilized genetic algorithms to solve the network controllability problem.
Tailored the algorithm for disease-specific protein-protein interaction networks.
Tested the algorithm on various cancer and random network models (Erdos-Renyi, Scale-Free, Small World).

Main Results:

The proposed genetic algorithm demonstrates superior efficiency in identifying relevant drug targets.
The method effectively maximizes the use of FDA-approved drug targets for repurposing.
Performance was validated across diverse network structures.

Conclusions:

This genetic algorithm offers an advanced computational solution for network controllability.
The approach significantly advances therapeutic and drug repurposing strategies.
Provides a more efficient method for identifying key targets in disease networks.